CN104910068B - A kind of synthetic method of the tosilate of 2 cyano group isonicotinic acid hydrazide 1.5 - Google Patents

A kind of synthetic method of the tosilate of 2 cyano group isonicotinic acid hydrazide 1.5 Download PDF

Info

Publication number
CN104910068B
CN104910068B CN201510201767.5A CN201510201767A CN104910068B CN 104910068 B CN104910068 B CN 104910068B CN 201510201767 A CN201510201767 A CN 201510201767A CN 104910068 B CN104910068 B CN 104910068B
Authority
CN
China
Prior art keywords
cyano group
isonicotinic acid
room temperature
tosilate
stirred
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN201510201767.5A
Other languages
Chinese (zh)
Other versions
CN104910068A (en
Inventor
陈冬寅
吴剑虹
李婷
熊正新
李飞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Medical University
Original Assignee
Nanjing Medical University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Medical University filed Critical Nanjing Medical University
Priority to CN201510201767.5A priority Critical patent/CN104910068B/en
Publication of CN104910068A publication Critical patent/CN104910068A/en
Application granted granted Critical
Publication of CN104910068B publication Critical patent/CN104910068B/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/86Hydrazides; Thio or imino analogues thereof

Abstract

A kind of synthetic method of the tosilate of 2 cyano group isonicotinic acid hydrazide 1.5,2 cyano group iso methyl nicotinates are used for initiation material, 2 cyano group isonicotinic acid are obtained by basic hydrolysis, in the presence of condensing agent, it is condensed with tert-butoxycarbonyl hydrazine, condensation product obtains target compound with the hydrolysis of p-methyl benzenesulfonic acid monohydrate.The technique does not need high temperature or low-temp reaction, it is not necessary to inert gas shielding, and all reaction dissolvents need not be without water pretreatment, intermediate without purification, and reaction condition is gentle, simple to operate, is adapted to industrial production.

Description

A kind of synthetic method of the tosilate of 2- cyano group isonicotinic acid hydrazide 1.5
Technical field
The invention belongs to pharmaceutical field, and in particular to a kind of synthesis of the tosilate of 2- cyano group isonicotinic acid hydrazide 1.5 Method.
Background technology
Toby department he(Topiroxostat)For Fuji's pharmacy and three and chemical joint development anti-antihyperuricemic of new generation Disease drug, the tosilate of 2- cyano group isonicotinic acid hydrazide 1.5 is the key intermediate (Chinese patent for synthesizing Topiroxostat 2002819276.1).The tosilate of document report (Chinese patent 2002819276.1) 2- cyano group isonicotinic acid hydrazide 1.5 is adopted It is that raw material reacts preparation by 4 steps with isonicotinic acid N- oxides, wherein, the reaction of isonicotinic acid N- oxides and ethyl chloroformate is needed To be carried out under -15 DEG C, anhydrous, inert gas shielding, reaction condition is harsher(Fig. 1-route 1).Can also be different by 2- cyano group Methyl nicotinate is raw material, directly and hydrazine reaction, obtains 2- cyano group isonicotinic acid hydrazide, but is due to that hydrazine high poison is inflammable, and industrial production is deposited In potential safety hazard(Fig. 1-route 3).
Therefore, the present invention uses 2- cyano group iso methyl nicotinate for initiation material, hydrolyzed by alkali such as sodium carbonate, potassium carbonate etc. 2- cyano group isonicotinic acid is obtained, in condensing agent such as N, N '-dicyclohexylcarbodiimide, 1- ethyls-(3- dimethylaminopropyls) carbon In the presence of diimmonium salt hydrochlorate etc., it is condensed with tert-butoxycarbonyl hydrazine, the hydrolysis of condensation product p-methyl benzenesulfonic acid monohydrate is obtained Obtain target compound.Due to there is ester bond and cyano group, under strongly alkaline conditions, ester bond simultaneously in 2- cyano group iso methyl nicotinate molecules Hydrolyzed simultaneously with cyano group, it is impossible to obtain expected product 2- cyano group isonicotinic acid.By inventor's test of many times, discovery uses carbonic acid Sodium, potassium carbonate etc. are hydrolyzed, in that context it may be convenient to obtain expected product 2- cyano group isonicotinic acid.2- cyano group isonicotinic acid and tert-butoxycarbonyl The condensation of hydrazine, can first be prepared into the different nicotinoyl chlorine of 2- cyano group, with the different nicotinoyl of 2- cyano group using thionyl chloride by 2- cyano group isonicotinic acid Chlorine is condensed with tert-butoxycarbonyl hydrazine, but passes through inventor's test of many times, and this method yield is very low, and environmental pollution is big, Be not suitable for industrial production.
The content of the invention
The technical problem of solution:The present invention provides a kind of synthesis side of the tosilate of 2- cyano group isonicotinic acid hydrazide 1.5 Method, uses 2- cyano group iso methyl nicotinate for initiation material, is reacted by 3 steps, obtains key intermediate 2- cyano group isonicotinic acid hydrazides 1.5 tosilate, the technique after improvement does not need high temperature or low-temp reaction, and reaction condition is gentle, and intermediate need not be carried It is pure, it is simple to operate, it is adapted to industrial production.
Technical scheme:A kind of synthetic method of the tosilate of 2- cyano group isonicotinic acid hydrazide 1.5, preparation process is:Adopt It is initiation material with 2- cyano group iso methyl nicotinates, 2- cyano group isonicotinic acid is obtained by basic hydrolysis, in the presence of condensing agent, with uncle Butoxy carbonyl hydrazine is condensed to yield condensation product;Wherein, the ratio between amount of material of 2- cyano group iso methyl nicotinate and alkali is 1:2-1:3, The ratio between amount of material of 2- cyano group isonicotinic acid and tert-butoxycarbonyl hydrazine is 1:1.5-1:3.
The alkali is sodium carbonate or potassium carbonate.
The condensing agent is N, N '-dicyclohexylcarbodiimide or 1- ethyls-(3- dimethylaminopropyls) carbodiimide Hydrochloride.
A kind of synthetic method of the tosilate of 2- cyano group isonicotinic acid hydrazide 1.5, step is:2- cyano group iso methyl nicotinates In 0.05mol, tetrahydrofuran 50mL, isopropanol 50mL, water 30mL suspension, it is stirred at room temperature down and carbonic acid sodium powder is added portionwise Last 0.1mol, is finished, and room temperature continues stirring reaction 2 hours, concentrated hydrochloric acid 0.1mol is added dropwise, 70 DEG C are filtered to remove inorganic salts, filtrate Concentration, obtains white solid;2- cyano group isonicotinic acid 0.05mol, tetrahydrofuran 150mL, 1- ethyl-(3- dimethylaminopropyls) carbon Diimmonium salt hydrochlorate 0.055mol, the g of I-hydroxybenzotriazole 0.5, tert-butoxycarbonyl hydrazine 0.075mol, are stirred at room temperature 48 small When, insoluble matter is filtered to remove, filtrate concentration adds ethyl acetate 150mL, washed with water 50mL, organic layer anhydrous sodium sulfate 10.0g is dried, and filtering, filtrate adds p-methyl benzenesulfonic acid monohydrate 0.1mol, and reaction 24 hours is stirred at room temperature, and filtering obtains white Color solid.
Beneficial effect:The technique does not need high temperature or low-temp reaction, it is not necessary to inert gas shielding, all reaction dissolvents Need not be gentle without water pretreatment, reaction condition, intermediate is simple to operate without purification, is adapted to industrial production.
Brief description of the drawings
Fig. 1 is the synthetic route chart of the tosilate of 2- cyano group isonicotinic acid hydrazide 1.5.
Embodiment
The following examples can make those skilled in the art to be fully understood by the present invention, but not limit this in any way Invention.
The synthesis of the 2- cyano group isonicotinic acid of embodiment 1
2- cyano group iso methyl nicotinate 8.1g (0.05mol), tetrahydrofuran 50mL, isopropanol 50mL, water 30mL suspension In liquid, it is stirred at room temperature down and the g of powdered sodium carbonate 10.6 (0.1mol) is added portionwise, finish, room temperature continues stirring reaction 2 hours, drop Enriching hydrochloric acid 8.4mL (0.1mol), 70 DEG C are filtered to remove inorganic salts, and filtrate concentration obtains the g of white solid 7.2, yield 97.3%. Product is verified:7.98-7.99 (d, 1H), 8.18 (s, 1H), 8.70-8.72 (d, 1H).ESI-MS: 147.0 ([M-H]-) 。
The synthesis of the 2- cyano group isonicotinic acid of embodiment 2
2- cyano group iso methyl nicotinate 8.1g (0.05mol), tetrahydrofuran 50mL, isopropanol 50mL, water 30mL suspension In liquid, it is stirred at room temperature down and the g of potassium carbonate powder 20.1 (0.15mol) is added portionwise, finish, room temperature continues stirring reaction 2 hours, Concentrated hydrochloric acid 12.8mL (0.15mol) is added dropwise, 70 DEG C are filtered to remove inorganic salts, and filtrate concentration obtains the g of white solid 7.1, yield 95.6%.Product is verified:7.98-7.99 (d, 1H), 8.18 (s, 1H), 8.70-8.72 (d, 1H).ESI-MS: 147.0 ([M-H]-) 。
The synthesis of the tosilate of 3 2- cyano group isonicotinic acid hydrazide of embodiment 1.5
Use the gained 2- cyano group isonicotinic acid 7.4g (0.05mol) of embodiment 1 or 2, tetrahydrofuran 150mL, N, the rings of N '-two Hexyl carbodiimide 11.3g (0.055mol), the g of DMAP 0.1, tert-butoxycarbonyl hydrazine 9.9g (0.075mol), is stirred at room temperature 48 hours, is filtered to remove insoluble matter, and filtrate concentration adds ethyl acetate 150mL, uses water 50mL Washing, organic layer is dried with anhydrous sodium sulfate 10.0g, and filtering, filtrate adds p-methyl benzenesulfonic acid monohydrate 19.0g (0.1mol), is stirred at room temperature reaction 24 hours, and filtering obtains the g of white solid 15.5, yield 73.8%.Product is verified:1H-NMR (DMSO-d6) δ(ppm): 2.28 (s, 4.5H), 7.11-7.14 (d, 3H), 7.49-7.52 (d, 3H), 8.09- 8.10 (d, 1H), 8.37 (s, 1H), 8.96-8.98(d, 1H). ESI-MS: 163.0 ([M+H]+).
The synthesis of the tosilate of 4 2- cyano group isonicotinic acid hydrazide of embodiment 1.5
Use the gained 2- cyano group isonicotinic acid 7.4g (0.05mol) of embodiment 1 or 2, tetrahydrofuran 150mL, 1- ethyl-(3- Dimethylaminopropyl) carbodiimide hydrochloride 10.5g (0.055mol), the g of I-hydroxybenzotriazole 0.5, tert-butoxy carbonyl Base hydrazine 19.8g (0.15mol), is stirred at room temperature 48 hours, is filtered to remove insoluble matter, and filtrate concentration adds ethyl acetate 150mL, is washed with water 50mL, and organic layer is dried with anhydrous sodium sulfate 10.0g, and filtering, filtrate adds p-methyl benzenesulfonic acid one and is hydrated Thing 19.0g (0.1mol), is stirred at room temperature reaction 24 hours, and filtering obtains the g of white solid 15.6, yield 74.3%.Product is verified :1H-NMR(DMSO-d6) δ(ppm): 2.28 (s, 4.5H), 7.11-7.14 (d, 3H), 7.49-7.52 (d, 3H), 8.09-8.10 (d, 1H), 8.37 (s, 1H), 8.96-8.98(d, 1H). ESI-MS: 163.0 ([M+H]+).
The synthesis of the tosilate of 5 2- cyano group isonicotinic acid hydrazide of embodiment 1.5
Use the gained 2- cyano group isonicotinic acid 7.4g (0.05mol) of embodiment 1 or 2, tetrahydrofuran 150mL, N, the rings of N '-two Hexyl carbodiimide 11.3g (0.055mol), tert-butoxycarbonyl hydrazine 9.9g (0.075mol), is stirred at room temperature 72 hours, mistake Insoluble matter is filtered, filtrate concentration adds ethyl acetate 150mL, washed with water 50mL, organic layer anhydrous sodium sulfate 10.0g Dry, filtering, filtrate adds p-methyl benzenesulfonic acid monohydrate 19.0g (0.1mol), reaction 24 hours is stirred at room temperature, filtering is obtained The g of white solid 15.0, yield 71.4%.Product is verified:1H-NMR(DMSO-d6) δ(ppm): 2.28 (s, 4.5H), 7.11-7.14 (d, 3H), 7.49-7.52 (d, 3H), 8.09-8.10 (d, 1H), 8.37 (s, 1H), 8.96- 8.98(d, 1H). ESI-MS: 163.0 ([M+H]+)。

Claims (1)

1. a kind of synthetic method of the tosilate of 2- cyano group isonicotinic acid hydrazide 1.5, it is characterised in that step is:2- cyano group is different In methyl nicotinate 0.05mol, tetrahydrofuran 50mL, isopropanol 50mL, water 30mL suspension, it is stirred at room temperature down and is added portionwise Powdered sodium carbonate 0.1mol, is finished, and room temperature continues stirring reaction 2 hours, is added dropwise concentrated hydrochloric acid 0.1mol, 70 DEG C be filtered to remove it is inorganic Salt, filtrate concentration, obtains white solid 2- cyano group isonicotinic acid;2- cyano group isonicotinic acid 0.05mol, tetrahydrofuran 150mL, 1- ethyl- (3- dimethylaminopropyls) carbodiimide hydrochloride 0.055mol, the g of I-hydroxybenzotriazole 0.5, tert-butoxycarbonyl hydrazine 0.15mol, is stirred at room temperature 48 hours, is filtered to remove insoluble matter, and filtrate concentration adds ethyl acetate 150mL, washed with water 50mL Wash, organic layer is dried with anhydrous sodium sulfate 10.0g, filtering, filtrate adds p-methyl benzenesulfonic acid monohydrate 0.1mol, is stirred at room temperature Reaction 24 hours, filtering, obtains white solid.
CN201510201767.5A 2015-04-24 2015-04-24 A kind of synthetic method of the tosilate of 2 cyano group isonicotinic acid hydrazide 1.5 Expired - Fee Related CN104910068B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510201767.5A CN104910068B (en) 2015-04-24 2015-04-24 A kind of synthetic method of the tosilate of 2 cyano group isonicotinic acid hydrazide 1.5

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510201767.5A CN104910068B (en) 2015-04-24 2015-04-24 A kind of synthetic method of the tosilate of 2 cyano group isonicotinic acid hydrazide 1.5

Publications (2)

Publication Number Publication Date
CN104910068A CN104910068A (en) 2015-09-16
CN104910068B true CN104910068B (en) 2017-07-14

Family

ID=54079569

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510201767.5A Expired - Fee Related CN104910068B (en) 2015-04-24 2015-04-24 A kind of synthetic method of the tosilate of 2 cyano group isonicotinic acid hydrazide 1.5

Country Status (1)

Country Link
CN (1) CN104910068B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106124662A (en) * 2016-07-15 2016-11-16 江苏悦兴医药技术有限公司 The high performance liquid chromatography method for detecting purity that a kind of 2 cyano group 4 pyridinecarboxylate are kept completely separate with its major impurity
CN110981795B (en) * 2019-12-18 2021-02-12 武汉世纪久海检测技术有限公司 Method for preparing 2-aminoacyl isonicotinic acid by using methyl 2-cyanoisonicotinate

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055085A1 (en) * 1999-08-19 2003-03-20 Wagenen Bradford Van Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
CN1561340A (en) * 2002-01-28 2005-01-05 株式会社富士药品 Novel 1,2,4-triazole compound
CN103724329A (en) * 2013-12-23 2014-04-16 济南百诺医药科技开发有限公司 Preparation method of 4-[5-(pyridyl-4-yl)-1H-[1,2,4]triazolyl-3-yl]pyridyl-2-formonitrile
CN104151297A (en) * 2014-08-27 2014-11-19 庄妍 Preparation of 4-[5-(pyridine-4-yl)-1H-[1,2,4]triazole-3-yl]pyridine-2-formonitrile

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030055085A1 (en) * 1999-08-19 2003-03-20 Wagenen Bradford Van Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
CN1561340A (en) * 2002-01-28 2005-01-05 株式会社富士药品 Novel 1,2,4-triazole compound
CN103724329A (en) * 2013-12-23 2014-04-16 济南百诺医药科技开发有限公司 Preparation method of 4-[5-(pyridyl-4-yl)-1H-[1,2,4]triazolyl-3-yl]pyridyl-2-formonitrile
CN104151297A (en) * 2014-08-27 2014-11-19 庄妍 Preparation of 4-[5-(pyridine-4-yl)-1H-[1,2,4]triazole-3-yl]pyridine-2-formonitrile

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
Discovery of 3-(3-cyano-4-pyridyl)-5-(4-pyridyl)-1,2,4-triazole, FYX-051-a xanthine oxidoreductase inhibitor for the treatment of hyperuricemia;Takahiro Sato,等;《Bioorganic & Medicinal Chemistry Letters》;20090902(第21期);第6225-6229页 *
The Direct Formation of 2-Cyano-4-amidopyridine via α-Cyanation of 4-Amidopyridine N-Oxide with Dimethylcarbamoyl Chloride and Cheap Potassium Cyanide;Zhibao Huo,等;《Acta Chim. Slov.》;20091231;第56卷(第3期);第659-663页 *
异烟肼合成方法的改进;戚晓菲,等;《黑龙江医药科学》;19981031;第21卷(第05期);第36-37页 *

Also Published As

Publication number Publication date
CN104910068A (en) 2015-09-16

Similar Documents

Publication Publication Date Title
CN112533908B (en) Synthetic method of calicheazine
CN104130261A (en) Idelalisib synthetic method
CN1982315A (en) Synthesis of cefaclor
CN109320498A (en) The bromo- 1-(3- chloro-2-pyridyl of 3-) -1H- pyrazoles -5- formic acid alkyl ester preparation method
CN102796079B (en) A kind of preparation method of methanesulfonic acid fluorine imatinib
CN104910068B (en) A kind of synthetic method of the tosilate of 2 cyano group isonicotinic acid hydrazide 1.5
CN106279104A (en) A kind of process modification method preparing succinum love song Ge Lieting
CN105111197A (en) Synthesis methods of raltitrexed
CN107200707B (en) Preparation method of pimavanserin
CN103896870A (en) Preparation method of deuterium labeled Ritonavir
CN106749071A (en) A kind of preparation method of the tetrazine compound of aromatics 1,2,4,5
CN106565607A (en) Synthetic method of L-carnosine
CN106588921B (en) A kind of synthetic method of the methyl formate of 7 azaindole 3
CN112679407B (en) Preparation method of chiral 5-substituted proline compound
CN109232457A (en) A kind of preparation method of Linezolid
CN105294501B (en) A kind of preparation method of Carfilzomib midbody compound
CN106946724A (en) The synthetic method of the benzyl malonic acid mono ethyl ester of 2 acetylamino of monoamine base inhibitor class intermediate 2
CN104072409B (en) A kind of synthetic method of pyridine amides
CN105481779B (en) Anticancer drug Rociletinib and its intermediate preparation
CN101857575A (en) Industrial preparation method of 5-methylpyrazin-2-amine
CN104610133A (en) Method for synthesizing novel anticancer medicine entinostat
CN104292133A (en) Method for synthesizing anti-cancer drug vorinostat
CN106518751B (en) Method for preparing pimavanserin
CN102875460A (en) Method for preparing sorafenib
CN107089928A (en) The synthetic method of N Boc L propargylglycines

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
CB03 Change of inventor or designer information

Inventor after: Chen Dongyin

Inventor after: Wu Jianhong

Inventor after: Li Ting

Inventor after: Xiong Zhengxin

Inventor after: Li Fei

Inventor before: Chen Dongyin

Inventor before: Li Fei

Inventor before: Li Ting

Inventor before: Xiong Zhengxin

COR Change of bibliographic data
GR01 Patent grant
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20170714

Termination date: 20180424